Literature DB >> 9009832

Molecular biology and pathogenesis of prion diseases.

S B Prusiner1.   

Abstract

Prions cause a group of human and animal neurodegenerative diseases, which are now classified together because their etiology and pathogenesis, involve modification of the prion protein (PrP). Prion diseases are manifest as infectious, genetic and sporadic disorders. These diseases can be transmitted among mammals by the infectious particle designated 'prion'. Despite intensive searches over the past three decades, no nucleic acid has been found within prions, yet a modified isoform of the host-encoded PrP designated PrPSc is essential for infectivity. In fact, considerable experimental data argue that prions are composed exclusively of PrPSc. Earlier terms used to describe the prion diseases include transmissible encephalopathies, spongiform encephalopathies and slow virus diseases. The human prion disorders include kuru, Creutzfeldt-Jackob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS) and fatal familial insomnia (FFI).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9009832     DOI: 10.1016/s0968-0004(96)10063-3

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  59 in total

1.  Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.

Authors:  D T Downing; N D Lazo
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

2.  Conformational behavior of ionic self-complementary peptides.

Authors:  M Altman; P Lee; A Rich; S Zhang
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

3.  Genetic variability of the coding region for the prion protein gene (PRNP) in gayal (Bos frontalis).

Authors:  Dongmei Xi; Qing Liu; Jianhong Guo; Hongman Yu; Yuai Yang; Yiduo He; Huaming Mao; Xiao Gou; Weidong Deng
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

4.  Molecular dynamics simulation of dimeric and monomeric forms of human prion protein: insight into dynamics and properties.

Authors:  Masakazu Sekijima; Chie Motono; Satoshi Yamasaki; Kiyotoshi Kaneko; Yutaka Akiyama
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

5.  Two-steps control of cellular prion physiology by the extracellular regulated kinase-1 (ERK1).

Authors:  Frédéric Checler
Journal:  Prion       Date:  2012 Jan-Mar       Impact factor: 3.931

Review 6.  Interpreting functional effects of coding variants: challenges in proteome-scale prediction, annotation and assessment.

Authors:  Khader Shameer; Lokesh P Tripathi; Krishna R Kalari; Joel T Dudley; Ramanathan Sowdhamini
Journal:  Brief Bioinform       Date:  2015-10-22       Impact factor: 11.622

7.  Rapid formation of amyloid from alpha-monomeric recombinant human PrP in vitro.

Authors:  Abdessamad Tahiri-Alaoui; William James
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

8.  An unstructured region is required by GAV homologue for the fibrillization of host proteins.

Authors:  Li-Na Ji; Hai-Ning Du; Feng Zhang; Hong-Tao Li; Xiao-Ying Luo; Jun Hu; Hong-Yu Hu
Journal:  Protein J       Date:  2005-05       Impact factor: 2.371

9.  The FMO protein is related to PscA in the reaction center of green sulfur bacteria.

Authors:  John M Olson; Jason Raymond
Journal:  Photosynth Res       Date:  2003       Impact factor: 3.573

10.  Misfolding pathways of the prion protein probed by molecular dynamics simulations.

Authors:  Alessandro Barducci; Riccardo Chelli; Piero Procacci; Vincenzo Schettino
Journal:  Biophys J       Date:  2004-11-19       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.